We report here initial results using localised in vivo 31P
Summary Photodynamic therapy (PDT) is efficacious in the treatment of small malignant lesions when all cells in the tumour receive sufficient drug, oxygen and light to induce a photodynamic effect capable of complete cytotoxicity. In large tumours, only partial effectiveness is observed presumably because of insufficient light penetration into the tissue. The heterogeneity of the metabolic response in mammary tumours following PDT has been followed in vivo using localised phosphorus NMR spectroscopy. Alterations in nucleoside triphosphates (NTP), inorganic phosphate (Pi) and pH within localised regions of the tumour were monitored over 24-48 h following PDT irradiation of the tumour. Reduction of NTP and increases in P, were observed at 4-6 h after PDT irradiation in all regions of treated tumours. The uppermost regions of the tumours (those nearest the skin surface and exposed to the greatest light fluence) displayed the greatest and most prolonged reduction of NTP and concomitant increase in Pi resulting in necrosis. The metabolite concentrations in tumour regions located towards the base of the tumour returned to near pre-treatment levels by 24-48 h after irradiation. The ability to follow heterogeneous metabolic responses in situ provides one means to assess the degree of metabolic inhibition which subsequently leads to tumour necrosis.
Tumour heterogeneity plays an important role in the treatment of malignancy and therapeutic response. Histopathological or biochemical evaluation of tumour samples can provide detailed localised information, but since the sample is evaluated ex vivo, the information may not accurately reflect the physiologic state of the tissue in situ. Ex vivo evaluations can only be performed on a sample at one selected time point, which make studies that monitor the time course of physiological or pathological change, or that monitor the course of therapeutic response, difficult and variable. Futhermore, sampling is usually limited to random or specifically selected regions of the whole tissue or lesion. In vivo, nuclear magnetic resonance spectroscopy and imaging can produce multiple, localised samplings over the entire tissue volume in situ, generating an assessment of tissue physiology and pathology at a microenvironmental level. Since the NMR techniques are non-invasive, assessments can be continuously monitored over the time course of a therapeutic response.
We report here initial results using localised in vivo 31P NMR spectroscopy and 'H NMR imaging to assess mammary tumour response to photodynamic therapy (PDT). PDT consists of the systemic administration of a photosensitising dye, e.g. the hematoporphyrin derivative Photofrin II, reported to be preferentially retained in tumour tissue (Kessel, 1986; Schneckenburger et al., 1987; Dougherty & Mang, 1987) , followed by irradiation of the lesion with visible light. The cytotoxic agent responsible for necrosis is reported to be the highly reactive singlet oxygen species formed by the reaction of the excited porphyrin triplet with dioxygen (Weishaupt et al., 1979; Stenstrom et al., 1980; Parker, 1987) . It has been suggested that tumour cell death results directly from intracellular damage to the mitochrondria (Sandberg & Romslo, 1980; Berns et al., 1982; Gibson & Hilf, 1983; Hilf et al., 1984) , or indirectly, from damage to tumour vasculature (Selman et al., 1984; Star et al., 1986; Fingar & Henderson, 1987; Nelson et al., 1988) . Either mechanism may produce decreases in high energy phosphate metabolism. Dramatic reduction in average nucleoside triphosphate (NTP) levels of whole tumours, accompanied by significant increases in inorganic phosphate (Pi) within the first hour following PDT irradiation of tumours, were demonstrated using in vivo 31P NMR spectroscopy (Ceckler et al., 1986; Hilf et al., 1987) . At 24h after irradiation, relative tumour metabolite levels returned to near pre-irradiation levels, however histological evaluation demonstrated a sharp demarcation between viable and necrotic regions in the tumour (Hilf et al., 1987) . This depth dependent necrosis, which developed at long times after irradiation, combined with the preceding depletion of whole tumour NTP levels, suggests the presence of a threshold for effective cytotoxicity based on the extent of light penetration (Wilson et al., 1985) . Below such a threshold, tumour metabolism apparently goes through transient, sub-lethal, and reversible inhibition. Employing spatially localised NMR techniques, data presented here demonstrate the occurrence of physiological heterogeneity and subsequent development of localised necrosis in mammary tumours following PDT treatment.
Materials and methods
Tumours and photodynamic therapy protocols R3230AC mammary tumours were implanted subcutaneously in the axillary region of 80-100 g female Fischer rats by the sterile trochar method (Hilf et al., 1965) . Ten to 17 days after tumour implantation (tumour size approximately 1 cm in diameter), host animals were administered intraperitoneally (i.p.) 5 mg kg-' Photofrin II (Quadra Logic Technologies, Inc., Vancouver, B.C., Canada), a preparation of hematoporphyrin derivative enriched in hydrophobic components. At 24 h after drug administration, the tumours were irradiated using a Coherent Inova 90 argon pumped tunable dye laser (Coherent Inc., Palo Alto, California) operated at 630nm and coupled to a flexible optic fibre fitted with a cylindrical lens (Optifrin, Grand Island, New York). The output from the fibre-lens system was focused to produce a 1 cm diameter beam with an optical power density of 200 mW cm-2 incident at the tumour surface (which will subsequently be referred to as the top of the tumour). Tumours (Ng & Glickson, 1985) . The coil was brought to resonance with a parallel capacitor and a balanced capacitive matching circuit. A 4" diameter birdcage coil (Hayes et al., 1985; Hayes, 1987) was positioned around the entire animal with the 31P coil in place around the tumour and coupling between the coils was minimised by orienting the irradiating B, field orthogonal to each other. The animal holder was then placed on a cradle which could be vertically adjusted to position the tumour in the centre of the magnet.
Tumour "P spectra Localised phosphorus spectra were acquired using a onedimensional phase encode technique that generates spectra at different spatial offsets (Brown et al., 1982; Mareci & Brooker, 1984) . Each spatially selected spectrum represents signal from an approximately 2 mm thick section perpendicular to the direction of the applied field gradient. A proton image was used to position the animal and adjust the field-of-view to encompass a region somewhat larger than the tumour diameter prior to acquisition of the 31P spectra. The spatially selective pulse sequence employs a 900 pulse (approximately 10 gs), a 2 ms half-cycle sine-shaped gradient pulse, a 180°C pulse, followed by a 2ms delay and acquisition of the second half of the echo. The magnitude of the gradient is determined by the field-of-view and is incremented from minimum to maximum in as many steps as the number of localised sections desired through the tumour. The recycle time was 5 s, and the spectral width was + 1,000 Hz acquired with quadrature detection and 4K data points. Typically, 128 transients were acquired per level with total acquisition times for the spectral set of about 1.5 h. Whole tumour spectra were acquired with this spin-echo sequence using the same acquisition parameters, but with the gradient amplitude set to zero. The magnet field homogeneity was adjusted by shimming on the proton signal with typical 'H linewidths of 20-30 Hz.
Two dimensional Fourier transformation of the data set yields 3'P spectra as a function of position in the tumour. The resulting spectra are presented in the absorption mode with the whole tumour spectrum (no field gradient) as the phase reference (Barker & Ross, 1987 We note that the recycle delay of 5 s is not long compared to all T, values in the system, which leads to partially Tlweighted "31P spectra. This situation is the norm for in vivo "P spectroscopy. While resonance intensity distortions result from this acquisition in a partially saturated mode as for the T2 effects, these should be the same for all slices, and, thus, not affect the inter-slice comparisons.
Tumour 'H spectra Whole tumour and localised proton spectra were acquired with the same protocol and coil as for 3'P spectra. The acquisition parameters were adjusted to account for the higher signal-to-noise and the untuned probe. The recycle time was 2 s, the spectral width was ± 2,000 Hz and 2K data points were collected. The 'H 900 pulse width was approximately 20 lss in the 3'P coil and four transients per level were acquired.
Proton images Proton images were acquired using a standard spin-echo phase-encode sequence. TI-weighted images were acquired using a recycle time (TR) of 400 ms and echo delay time (TE) of 16 ms. T2-weighted images were acquired using a TR of 2,200 ms and a TE of 90 ms. For all images the slice thickness was 2 mm, the field of view 50 x 50 mm, and two acquisitions per phase encode step were collected.
pH determinations The intracellular pH was determined from the chemical shift of the inorganic phosphate peak in the 3'P spectra (Gadian et al., 1982) . The phosphocreatine peak is typically used as the reference peak since its chemical shift is insensitive to pH in the physiologic range. However, since the level of phosphocreatine in these mammary tumours was often undetectable, the water 'H resonance was used as the "P chemical shift reference (Ackerman et al., 1981) . Whole tumour and localised proton spectra were acquired prior to the acquisition of the "P spectra.
Data analysis and presentation The "P spectra were fit using the routine GEMCAP supplied with the GE system software. This routine permits interactive adjustment of peak width, height, and position to generate a fit for each peak in the spectrum assuming a Lorentzian lineshape. The difference spectra between the acquired and the calculated spectrum were within the noise level. Peaks were not fit if peak heights were less than twice the noise level.
Resonance assignments are summarised in Figure la . The NTP and NDP peaks are predominantly due to ATP and ADP respectively (Rodrigues et al., 1988) . Contributions from other nucleoside triphosphates, such as GTP, are not resolved under our experimental conditions. Therefore, when discussing data obtained by NMR we refer to these peaks as NTP and NDP. We refer to ATP when discussing cellular metabolism. The P-NTP peak at approximately 20 p.p.m.
upfield from Pi, is used as a measure of NTP levels in tissues because this resonance has no contribution from NDP. Data for metabolite levels are presented as ratios of the peak areas for P-NTP and Pi. Measurement of absolute metabolite concentrations was not attempted because no appropriate intensity standard was employed during spectral acquisition.
Assignment of localised "P spectra to specific levels within the tumour was based on the corresponding localised 'H spectra which had the obvious advantage of a high signal-tonoise ratio. The first proton spectrum of the data set that showed a clearly resolved water peak was assigned to the base of the tumour and sequential spectra were then assigned to the adjacent levels in the tumour. The same spatial assignments were made for the 3'P localised spectral data sets. Three to five spectra from the localised "P data sets con- (vi) a-NTP, a-NDP, (vii) P-NTP. a, Whole tumour spectra. Times, in hours, after irradiation are indicated on each spectrum. b, Localised spectra acquired prior to PDT irradiation. The field of view was 16 mm so that each spectrum represents signal from a 2 mm slice taken normal to the direction of incident light. Levels corresponding to regions of the tumour are labelled with letters A-F. Signal from tumour is seen mostly in levels B-E. Level F corresponds to the top of the tumour, or the region closest to the incident light source. c, localised spectra acquired at 1.5-3 h, d, at 5.5-7 h, and e, at 22.5-24 h after PDT irradiation.
tained sufficient signal for analysis depending on the size of the tumour and position in the field of view. There were only two cases in which five levels could be assigned. In these cases, the spectra corresponding to the two levels furthest from the top of the tumour were averaged. The data were put into time blocks corresponding to control (i.e. prior to photo-irradiation), 0.3-4 h post irradiation, 4-7 h post irradiation and 19-29 h post irradiation. A total of nine animals were studied with a minimum of six in each time block. An additional four animals treated under the same protocol were included for the whole tumour data and a minimum of four animals per time point are presented.
The removal and repositioning of the host animal between each spectroscopic study may result in some overlap of regions from one set of localised spectra to another. However, based on the position of the signal within the field of view, the uncertainty is estimated to be less than half the width of one section, or approximately 1 mm. Figure 1 . Some broadening in the localised spectra is apparent and may be due to gradient induced eddy-current effects. A compromise in the echo delay time was made to minimise eddy-current effects and loss of signal because of transverse magnetisation decay. Decreased signal intensity in localised spectra corresponding to the top of the tumour is due to smaller tissue volumes. Decreased intensity in spectra from the base of the tumour may result from smaller tissue volume and a decreased excitation and reception sensitivity outside the r.f. coils. The level of NTP in the whole tumour spectra (Figure la) decreased but remained detectable at all times after irradiation. The localised spectra demonstrated a more extensive depletion of NTP and a greater increase in Pi levels in the top regions of the tumour compared to changes observed in the whole tumour spectra.
Systematic differences in Pi between tumour levels observed in the localised spectra developed by 3 h and were maintained, though to a lesser extent, at 24 h after irradiation.
Relative changes in Pi levels appeared to be of greater magnitude than alterations in the amounts of NTP. Although the NTP levels measured in different regions of the tumour differ prior to irradiation, all were reduced to approximately the same relative level by 3 h after irradiation. Differences in NTP between tumour levels were small except in the topmost region of the tumour, which showed an almost complete loss of NTP. 0-NTP to Pi ratios based on peak areas as a function of time after irradiation are presented in Figure 2 for the whole tumour (dashed lines) and from this same tumour for the localised regions (localised spectra shown in Figure 1 ). The levels are labelled in order from A at the base, i.e. furthest from the light source. (When level F could be assigned, the data were averaged with level E). In experiments not presented, the early metabolic response to PDT is less in skin than tumour tissue; therefore, averaging levels E and F yields an underestimate of the metabolic changes in the tumour tissue. The intensity ratios for the whole tumour spectra approximate the averages of the data obtained from the localised regions of the tumour.
The calculated pH prior to and after PDT for the whole tumour (dashed line) and the localised levels in this representative tumour are presented in Figure 3 . The top region of the tumour became more acidotic than the lower regions by 3 h after irradiation. The pH determined from the NMR spectra returned to pretreatment values in all regions of the tumour by 24 h after irradiation. Effects of PDT on proton images of a representative tumour T2-weighted proton images acquired from the tumour described above prior to irradiation, and at times immediately before acquisition of the localised 31P spectra, are shown in Figure 4 . T,-weighted images were of uniform intensity throughout the tumour before and at all times after PDT irradiation and are not presented. The high intensity region observed in the centre of the tumour in the T2-weighted images prior to and following irradiation is attributable to a region of spontaneously developed necrosis. As published previously (Hilf et al., 1987) Combined results for whole tumour and localised 3'P-NMR spectroscopy Tumour phosphate metabolite levels were determined prior to and at selected times after PDT irradiation. All animals were exposed to the same treatment protocol. Figure 5 depicts the whole tumour P-NTP/Pi ratios. A significant reduction in this ratio occurs from 2 to 7 h after PDT irradiation compared to pre-irradiation values (P <0.05 by the Student's t-test comparing control vs treated tumours).
The combined data for the P-NTP/Pi ratios obtained for the localised spectra are shown in Figure 6 . At 0-4 h post irradiation, the ,-NTP/Pi ratio decreases to approximately the same level in all regions of the tumour. After this time, an apparent heterogeneity in the response is evident, becoming more marked at 24 h post irradiation. Statistical analysis of these data by the Student's t-test for pair-wise comparisons demonstrates that the ,-NTP/Pi ratios for all tumour levels in the 0.3-4 h time block are significantly reduced when compared to controls (P <0.05). At 4-7 h after PDT irradiation, reduction in the P-NTP/Pi ratio was significant only when level E was compared to control levels. No significant differences were found in the ratios between 0.3-4 h vs 4-7 h PDT groups. At 24 h after PDT irradiation, the level E P-NTP/Pi ratios remained significantly reduced compared to all pre-treatment control levels. Inter- (Figure 6 ), followed by a gradual return to near pretreatment levels by [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] h, a finding which is in agreement with other investigators (Naruse et al., 1986b; Chopp et al., 1987 Chopp et al., , 1990 (Ceckler et al., 1986; Hilf et al., 1987 (Gibson et al., 1990) .
We have presented the data as the ratio of,-NTP to Pi here and previously (Ceckler et al., 1986; Hilf et al., 1987) . Since both NTP and Pi levels change in response to PDT, this choice of presentation may amplify or diminish the actual response. Though this presentation may not be ideal, alternatives require greater signal-to-noise ratios than available and it does provide a useful indicator of metabolic status. Since Pi is the product of ATP hydrolysis West-Jordan et al., 1987) Proton NMR images of treated tumour at 24 h after PDT, Figure 4 , clearly demonstrate an area of high intensity in the region nearest the light source extending to a maximum depth of about 2-3 mm. The presence of high intensity regions in a T2-weighted image corresponds to an increase in T2, which may result from an increase in water content or an increase in water mobility that is consistent with necrosis.
These high intensity regions observed in situ by 'H NMR were confirmed to arise from necrosis regions by gross histological evaluation of excised tumours. Within this necrotic region, a reduction of 0.3-4 pH units and a 3-fold increase in Pi was observed at 4-7 h after PDT irradiation. Necrosis detected by NMR imaging became apparent at times later than the most dramatic alterations in pH and metabolite concentrations observed using 31P spectroscopy.
The changes in 31P signal intensities reported here were not corrected for possible changes in 31P relaxation times. The 'H images of tumours before and after PDT irradiation suggest that there are increases in T2 relaxation times in regions of developing necrosis, though T, changes are less apparent.
Thus, the 31P signal intensities from spectra acquired with a spin-echo sequence under partially saturating conditions may reflect differential changes in the 31P NMR relaxation times caused by changes in the effective microdynamic viscosity.
The decrease in apparent viscosity in necrotic areas suggested by the proton image should increase the observed signal intensities with the short T2 signals like NTP, which would be affected the most. However, the NTP intensity in these regions is decreased in spite of these possible changes. Thus, the comparisons made are not invalidated by possible changes in the 31P relaxation times caused by the treatment.
The studies presented here show that there are several consequences of the photosensitisation events of PDT, which results in depth dependent metabolic responses within the tumour. A primary response may be direct tumour cell damage in the regions of the tumour where light intensity is highest. Cells in regions where the light is increasingly attenuated may undergo sublethal damage, a period of quiescence followed by repair and subsequently, a return to normal metabolic activity 24-48 h after irradiation. Vascular damage may also play a role in the long term metabolic response with the collapse of blood vessels over time compromising flow and perfusion in the top regions of the tumour. Blood vessels at greater depths in the tumour may become reversibly damaged allowing for repair and re-establishment of blood flow to the lower regions of the tumour.
The data presented here also suggest that there are significant metabolic changes occurring at early times following PDT that may be predictive of subsequent necrosis. The combination of increases in P, levels and decreases in pH appear to be the most predictive markers of subsequent necrosis following PDT. These data taken together with our previous study (Hilf et al., 1987) show that the changes in phosphate metabolites resulting from PDT preceed necrosis at the top of the tumours, when detected either via proton imaging or by histological examination, and changes in tumour size, results that agree with those of Dodd et al. (1989) . The fact that some regions of the tumour show reversible metabolic changes suggests that the damage in these regions was sub-lethal and repairable; in Figure 2, 
